Comex Reports The Gambia 30 - pharmaceutical products 3002 - human or animal blood

Deploy a report





Chart - The Gambia - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - The Gambia - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - The Gambia - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024
Belgium 324.542 3.960.678 4.133.318 8.606.301 3.729.119
Netherlands 1.053.776 15.380 8.776 513.152
South Korea 117.000 478.000 317.000 116.000 247.000
United States 1.081.959
Italy 466.544 208.649
France 209.898 165.005 3.864 3.534 250.290
Japan 157.344 33.784
Germany 23.645 61.942 40.521 19.164 19.021
Bulgaria 17.034 17.104 9.110 18.564 32.512
China 35.691 21.596 20.862 7.757
Others 15.341 56.669 12.682 9.111 5.594
Total 900,495 6,281,314 5,668,481 8,781,450 5,013,094

Chart - The Gambia - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - The Gambia - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - The Gambia - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Export Countries
 03 - 2025 04 - 2025 05 - 2025 06 - 2025 07 - 2025
Belgium 669 02 247.635
Bulgaria 31.419
Germany 1.547 2.133 88 2.489
South Korea 5.000
Netherlands 788 1.056
Sweden 1.120
France 196 48 252
China 480
South Africa 06
Total 2,027 2,808 1,404 8,326 280,363

Chart - The Gambia - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - The Gambia - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - The Gambia - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Import Countries
 2020 2021 2022 2023 2024
Belgium 38 54.728 40 29
Sweden 6.033
Netherlands 4.847
Spain 764
France 634 45
Germany 139 04
South Africa 10 10 53 27
Thailand 26
Canada 09
Total 653 38 60,911 93 5,742

Chart - The Gambia - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - The Gambia - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - The Gambia - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Import Countries
 04 - 2025
France 579
Total 579

Chart - The Gambia - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - The Gambia - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - The Gambia - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024
Importaciones
Belgium 324.542 3.960.678 4.133.318 8.606.301 3.729.119
Netherlands 1.053.776 15.380 8.776 513.152
South Korea 117.000 478.000 317.000 116.000 247.000
United States 1.081.959
Italy 466.544 208.649
France 209.898 165.005 3.864 3.534 250.290
Japan 157.344 33.784
Germany 23.645 61.942 40.521 19.164 19.021
Bulgaria 17.034 17.104 9.110 18.564 32.512
China 35.691 21.596 20.862 7.757
Others 15.341 56.669 12.682 9.111 5.594
Total 900,495 6,281,314 5,668,481 8,781,450 5,013,094

Date
Import Countries
 2020 2021 2022 2023 2024
Exportaciones
Belgium 38 54.728 40 29
Sweden 6.033
Netherlands 4.847
Spain 764
France 634 45
Germany 139 04
South Africa 10 10 53 27
Thailand 26
Canada 09
Total 653 38 60,911 93 5,742

Chart - The Gambia - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - The Gambia - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - The Gambia - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Export Countries
 03 - 2025 04 - 2025 05 - 2025 06 - 2025 07 - 2025
Importaciones
Belgium 669 02 247.635
Bulgaria 31.419
Germany 1.547 2.133 88 2.489
South Korea 5.000
Netherlands 788 1.056
Sweden 1.120
France 196 48 252
China 480
South Africa 06
Total 2,027 2,808 1,404 8,326 280,363

Date
Import Countries
 04 - 2025
Exportaciones
France 579
Total 579